Tech Company Financing Transactions

Orna Therapeutics Funding Round

Orna Therapeutics, operating out of Cambridge, secured $80 million in investment from F2 Ventures, MPM Capital and Taiho Ventures.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

620 Memorial Dr. 2nd Floor
Cambridge, MA 02139
USA

Phone

Undisclosed

Website

www.ornatx.com

Email Address

[email protected]

Overview

Orna Therapeutics is leaving linear thinking behind to create fully engineered circular RNA (oRNA) therapeutics -- an entirely new class of RNA medicines that can realize the full potential of RNA and which is poised to change the way we treat disease.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Thomas Barnes

        

Chief Financial Officer

John McCabe

        

Vice President

Gregory Motz

        

VP - Bus. Development

Brian Goodman

        

Browse more venture capital transactions:

Prev: 2/25/2021: PureStream Trading Technologies venture capital transaction
Next: 2/25/2021: Acumen venture capital transaction

Share this article

About Database of VC Transactions

Our team works diligently to report on funding rounds that are announced publicly. VC transactions on this site are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary